Cardiovascular effects of methyl methacrylate monomer

Area of Science:

• Orthopedic surgery
• Biomaterials science
• Cardiovascular physiology

Background:

• Methyl methacrylate monomer is a component of acrylic bone cement used in orthopedic procedures.
• Hemodynamic changes have been observed during orthopedic surgeries involving acrylic cement.
• The direct cardiorespiratory effects of circulating methyl methacrylate monomer in humans are not well-established.

Purpose of the Study:

• To investigate the cardiorespiratory effects of circulating methyl methacrylate monomer in humans.
• To compare human responses to those observed in canine models.
• To evaluate the role of circulating monomer as the sole cause of hemodynamic alterations during orthopedic procedures.

Main Methods:

• Review of existing literature on methyl methacrylate monomer toxicity and hemodynamic responses.
• Analysis of blood monomer levels in patients undergoing orthopedic surgery.
• Comparison of clinical findings with experimental data from canine studies.

Main Results:

• Human blood levels of methyl methacrylate monomer after orthopedic surgery are significantly lower than those causing cardiocirculatory alterations in dogs.
• The monomer levels achieved in clinical practice are unlikely to be the sole cause of observed hemodynamic changes.
• The direct cardiorespiratory sensitivity of humans to circulating monomer remains largely unknown.

Conclusions:

• Circulating methyl methacrylate monomer at clinically relevant concentrations is unlikely to be the primary cause of significant hemodynamic alterations in humans.
• The observed hemodynamic changes during orthopedic procedures may be multifactorial, involving factors beyond circulating monomer levels.
• Further research is needed to fully elucidate human cardiorespiratory sensitivity to methyl methacrylate monomer.